Skip to main content

Advertisement

SpringerLink
Log in

Effect of Lipid-Modifying Therapy on Long-Term Mortality After Abdominal Aortic Aneurysm Repair: A Systemic Review and Meta-Analysis

  • Scientific Review
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Several observational studies have demonstrated that lipid-modifying therapy may improve long-term survival in abdominal aortic aneurysm (AAA) patients after repair. We carried out a systematic review and meta-analysis of studies evaluating the effect of lipid-modifying therapy on long-term mortality.

Patients and methods

We conducted a systematic search of multiple databases up to April 2014. Studies that evaluated exposure to lipid-modifying therapy, reported mortality data and hazard ratio (HR) or provided survival curve for their estimation were included in the meta-analysis. Pooled HR estimates with 95 % confidence intervals (CIs) were calculated using the random-effects model.

Results

Eight studies (seven cohorts, one post hoc study of a randomization controlled trial) reporting 2,605 patients on lipid-modifying therapy were included. Meta-analysis showed a significant 39 % reduction in long-term mortality with lipid-modifying therapy (HR 0.61; 95 % CI 0.51–0.73). After exclusion of one study which was contributing to considerable heterogeneity, a significant 33 % reduction in mortality risk was a more conservative, consistent estimate (HR 0.67; 95 % CI 0.59–0.77).

Conclusion

Meta-analysis of studies supports a protective role of lipid-modifying therapy on mortality risk after AAA repair. Aggressive lipid intervention should be recommended to those who receiving AAA repair.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM (2011) Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 8(2):92–102

    Article  PubMed  Google Scholar 

  2. Hoornweg LL, Storm-Versloot MN, Ubbink DT, Koelemay MJ, Legemate DA, Balm R (2008) Meta analysis on mortality of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 35(5):558–570

    Article  CAS  PubMed  Google Scholar 

  3. Von Allmen RS, Powell JT (2012) The management of ruptured abdominal aortic aneurysms: screening for abdominal aortic aneurysm and incidence of rupture. J Cardiovasc Surg 53(1):69–76

    Google Scholar 

  4. Mani K, Bjorck M, Lundkvist J, Wanhainen A (2009) Improved long-term survival after abdominal aortic aneurysm repair. Circulation 120(3):201–211

    Article  PubMed  Google Scholar 

  5. Tornwall ME, Virtamo J, Haukka JK, Albanes D, Huttunen JK (2001) Life-style factors and risk for abdominal aortic aneurysm in a cohort of Finnish male smokers. Epidemiology 12(1):94–100

    Article  CAS  PubMed  Google Scholar 

  6. Wanhainen A, Bergqvist D, Boman K, Nilsson TK, Rutegard J, Bjorck M (2005) Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg 41(3):390–396

    Article  PubMed  Google Scholar 

  7. Eldrup N, Budtz-Lilly J, Laustsen J, Bibby BM, Paaske WP (2012) Long-term incidence of myocardial infarct, stroke, and mortality in patients operated on for abdominal aortic aneurysms. J Vasc Surg 55(2):311–317

    Article  PubMed  Google Scholar 

  8. Calabro P, Yeh ET (2005) The pleiotropic effects of statins. Curr Opin Cardiol 20(6):541–546

    Article  PubMed  Google Scholar 

  9. Liao JK (2005) Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol 96(5A):24F–33F

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Tousoulis D, Psarros C, Demosthenous M, Patel R, Antoniades C, Stefanadis C (2014) Innate and adaptiveinflammation as a therapeutic target in vascular disease: the emerging role of statins. J Am Coll Cardiol 63:2491–2502

    Article  CAS  PubMed  Google Scholar 

  11. Kertai MD, Boersma E, Westerhout CM, van Domburg R, Klein J, Bax JJ et al (2004) Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 16(2):96–103

    Article  Google Scholar 

  12. Ohrlander T, Dencker M, Dias NV, Gottsater A, Acosta S (2004) Cardiovascular predictors for long-term mortality after EVAR for AAA. Vasc Med 16(6):422–427

    Article  Google Scholar 

  13. Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA et al (2009) SVS practice guidelines for the care of patients with an abdominal aortic aneurysm: executive summary. J Vasc Surg 50(4):880–896

    Article  PubMed  Google Scholar 

  14. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

  15. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188

    Article  CAS  PubMed  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560

    Article  PubMed Central  PubMed  Google Scholar 

  17. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR (1991) Publication bias in clinical research. Lancet 337(8746):867–872

    Article  CAS  PubMed  Google Scholar 

  18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. De Martino RR, Eldrup-Jorgensen J, Nolan BW, Stone DH, Adams J, Bertges DJ et al (2014) Perioperative management with antiplatelet and statin medication is associated with reduced mortality following vascular surgery. J Vasc Surg 59(6):1615–1621

    Article  PubMed Central  PubMed  Google Scholar 

  20. McNally MM, Agle SC, Parker FM, Bogey WM, Powell CS, Stoner MC (2010) Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 51(6):1390–1396

    Article  PubMed  Google Scholar 

  21. Diehm N, Benenati JF, Becker GJ, Quesada R, Tsoukas AI, Katzen BT et al (2007) Anemia is associated with abdominal aortic aneurysm (AAA) size and decreased long-term survival after endovascular AAA repair. J Vasc Surg 46(4):676–681

    Article  PubMed  Google Scholar 

  22. de Bruin JL, Baas AF, Heymans MW, Buimer MG, Prinssen M, Grobbee DE et al (2014) Statin therapy is associated with improved survival after endovascular and open aneurysm repair. J Vasc Surg 59(1):39–44

    Article  PubMed  Google Scholar 

  23. Diehm N, Becker G, Katzen B, Benenati J, Kovacs M, Dick F (2008) Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis. VASA Zeitschrift fur Gefasskrankheiten 37(3):241–249

    Article  CAS  PubMed  Google Scholar 

  24. Lee HG, Clair DG, Ouriel K (2013) Ten-year comparison of all-cause mortality after endovascular or open repair of abdominal aortic aneurysms: a propensity score analysis. World J Surg 37(3):680–687. doi:10.1007/s00268-012-1863-y

    Article  PubMed  Google Scholar 

  25. Leurs LJ, Visser P, Laheij RJ, Buth J, Harris PL, Blankensteijn JD (2006) Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 14(1):1–8

    Article  PubMed  Google Scholar 

  26. Parmar GM, Lowman B, Combs BR, Taylor SM, Patterson MA, Passman MA et al (2013) Effect of lipid-modifying drug therapy on survival after abdominal aortic aneurysm repair. J Vasc Surg 58(2):355–362

    Article  PubMed  Google Scholar 

  27. Schouten O, Lever TM, Welten GM, Winkel TA, Dols LF, Bax JJ et al (2008) Long-term cardiac outcome in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 36(6):646–652

    Article  CAS  PubMed  Google Scholar 

  28. Norman PE, Semmens JB, Lawrence-Brown MM (2001) Long-term relative survival following surgery for abdominal aortic aneurysm: a review. Cardiovasc Surg 9(3):219–224

    Article  CAS  PubMed  Google Scholar 

  29. Vega de Ceniga M, Estallo L, Barba A, de la Fuente N, Viviens B, Gomez R (2010) Long-term cardiovascular outcome after elective abdominal aortic aneurysm open repair. Ann Vasc Surg 24(5):655–662

    Article  CAS  PubMed  Google Scholar 

  30. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA (2006) Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 333(7579):1149

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Stalenhoef AF (2009) The benefit of statins in non-cardiac vascular surgery patients. J Vasc Surg 49(1):260–265

    Article  PubMed  Google Scholar 

  32. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP (2008) Are statins an option in the management of abdominal aortic aneurysms? Vasc Endovasc Surg 42(2):128–134

    Article  Google Scholar 

  33. Liu PY, Liu YW, Lin LJ, Chen JH, Liao JK (2009) Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rhoassociated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 119(1):131–138

  34. Sakalihasan N, Limet R, Defawe OD (2005) Abdominal aortic aneurysm. Lancet 365(9470):1577–1589

  35. Hellenthal FA, Buurman WA, Wodzig WK, Schurink GW (2009) Biomarkers of abdominal aortic aneurysm progression. Part 2: inflammation. Nat Rev Cardiol 6(8):543–552

  36. Martinez-Pinna R, Lindholt JS, Blanco-Colio LM, Dejouvencel T, Madrigal-Matute J, Ramos-Mozo P et al (2010) Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution. Atherosclerosis 212(1):333–338

  37. Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C et al (2010) Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscl Throm Vas 30(2):360–367

  38. Steinmetz EF, Buckley C, Shames ML, Ennis TL, Vanvickle-Chavez SJ, Mao D (2005) Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 241(1):92–101

  39. Ferguson CD, Clancy P, Bourke B, Walker PJ, Dear A, Buckenham T et al (2010) Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J 159(2):307–313

  40. van der Meij E, Koning GG, Vriens PW, Peeters MF, Meijer CA, Kortekaas KE et al (2013) A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation. PLoS One 8(1):e53882

  41. Takagi H, Matsui M, Umemoto T (2010) A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion. J Vasc Surg 52(6):1675–1681

  42. Twine CP, Williams IM (2011) Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms. Brit J Surg 98(3):346–353

Download references

Acknowledgments

This work was supported by grants from National Nature Science Foundation of China (81270396) and Nature Science Foundation of Jiangsu Province, China (BK2009035).

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

  1. Department of Vascular Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, People’s Republic of China

    Wenwen Zhang, Zhao Liu & Changjian Liu

Authors
  1. Wenwen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Changjian Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Changjian Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, W., Liu, Z. & Liu, C. Effect of Lipid-Modifying Therapy on Long-Term Mortality After Abdominal Aortic Aneurysm Repair: A Systemic Review and Meta-Analysis. World J Surg 39, 794–801 (2015). https://doi.org/10.1007/s00268-014-2858-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-014-2858-7

Keywords

Search

Navigation